The Technical Analyst
Signify Health, Inc. [SGFY]
Exchange: NYSE Sector: Healthcare Industry: Healthcare - Information Services
Signify Health, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.07% $30.49
America/New_York / 28 mar 2023 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 8 933.39 mill |
| EPS: | 0.430 |
| P/E: | 70.91 |
| Earnings Date: | Aug 01, 2023 |
| SharesOutstanding: | 292.99 mill |
| Avg Daily Volume: | 2.65 mill |
| RATING 2023-03-30 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/21 | 4/21 | 1/22 | 2/22 | 3/22 | 4/22 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 4.60x |
| Company: PE 70.91 | sector: PE 15.43 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.05x |
| Company: PE 70.91 | industry: PE 67.77 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 30.25 - 30.73 ( +/- 0.78%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-03-29 | Builder Josh | Buy | 145 011 | Class A Common Stock |
| 2023-03-29 | Builder Josh | Sell | 119 871 | Class A Common Stock |
| 2023-03-29 | Builder Josh | Sell | 145 011 | Class B Common Stock |
| 2023-03-29 | Builder Josh | Sell | 151 584 | Class A Common Stock |
| 2023-03-29 | Builder Josh | Sell | 145 011 | LLC Units in Cure Aggregator, LLC |
| INSIDER POWER |
|---|
| -29.70 |
| Last 100 transactions |
| Buy: 10 903 827 | Sell: 19 851 942 |
Forecast:
01:40 - $28.90
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $30.49 (0.07% ) |
| Volume | 9.63 mill |
| Avg. Vol. | 2.65 mill |
| % of Avg. Vol | 363.03 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SGFY
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
SGFY
Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers under the Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. The company serves health plans, governments, employers, health systems, and physician groups. The company operates in Norwalk, Connecticut, New York, New York, Dallas, Texas, South Dakota, Deerfield, Florida, and Rapid City. Signify Health, Inc. was founded in 2017 and is headquartered in Dallas, Texas.
Latest Press Releases
2023-03-27 06:45:00 - Press Release
Cvs Health To Close Acquisition Of Signify Health
Woonsocket, r.i. and dallas and new york , march 27, 2023 /prnewswire/ -- cvs health® (nyse: cvs) today announced it expects to complete its acquisition of signify health (nyse: sgfy) on or around march 29, 2023, subject to the satisfaction or waiver of the remaining customary closing conditions set forth in the merger agreement.
2023-03-06 09:03:00 - Press Release
Cardinal Health's Outcomes™ Collaborates With Signify Health To Offer In-home Medication Therapy Management
Dublin, ohio , march 6, 2023 /prnewswire/ -- cardinal health (nyse:cah) today announced its collaboration with signify health (nyse:sgfy) to offer in-home clinical and medication management services through its outcomes™ business. this collaboration will help reduce costs and eliminate gaps in care for more than 2.3 million members nationwide to support their treatment journey from prescription to pharmacy to home.
2022-10-04 11:20:00 - Press Release
Signify Health Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Adequacy Of Price And Process In Proposed Sale Of Signify Health, Inc. - Sgfy
New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of signify health, inc. (nyse: sgfy) to cvs health corporation (nyse: cvs). under the terms of the proposed transaction, shareholders of signify will receive $30.50 in cash for each share of signify that they own. ksf is seeking to determine whether this consideration and the process that led to it are adequate,
2022-09-26 00:00:00 - Press Release
Shareholder Investigation: Halper Sadeh Llc Investigates Gmtx, Fmtx, Trq, Sgfy
New york , sept. 26, 2022 /prnewswire/ -- halper sadeh llc, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: gemini therapeutics, inc. (nasdaq: gmtx) 's merger with disc medicine, inc. pre-merger gemini shareholders are expected to own approximately 28% of the combined company.
2022-09-19 01:48:00 - Press Release
Shareholder Investigation: Halper Sadeh Llc Investigates Ecom, Sgfy, Eq, Mtcr
New york , sept. 19, 2022 /prnewswire/ -- halper sadeh llc, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: channeladvisor corporation (nyse: ecom) 's sale to commercehub for $23.10 per share in cash.
Latest News
2024-01-09 20:06:37 - CNBC Television
CVS CEO talks integration of Oak Street Health and Signify
CVS CEO Karen Lynch joins 'Mad Money' host Jim Cramer to talk consumer behavior, weight loss drugs, store closures and more.
2023-11-29 05:31:35 - Finbold
Is it time to buy this market-beaten growth stock?
Investing is a complex game, but the aim is simple: Profit. Despite there being numerous avenues through which this objective can be achieved, many concentrate on short-term price movement and growth.
2023-03-28 03:52:04 - Zacks Investment Research
Strength Seen in Signify (SGFY): Can Its 5.8% Jump Turn into More Strength?
Signify (SGFY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
2023-03-24 06:45:00 - The Motley Fool
This Boring Business Could Be a Secret Weapon to Beat the Market
CVS has piled on debt to reinvent its business. The stock's been sold off in this high-interest-rate environment.
2023-03-20 22:56:07 - 24/7 Wall Street
These Are the Top 10 Holdings of George Soros
George Soros is considered to be among the most successful investors of all time. He managed client money from 1969 to 2011 and his Quantum Fund gave an average annual return of 30% from 1970 to 2000.
2023-03-13 15:29:48 - InvestorPlace
3 Growth Stocks That Could Disrupt the Healthcare Industry
Healthcare growth stocks are often sought out by investors looking for market disruptors. That's because these stocks can potentially deliver high revenue growth, earnings, and stock price.
2023-02-06 19:34:04 - Zacks Investment Research
Time to Buy CVS Stock Before Crucial Q4 Earnings?
Trading near its 52-week lows and 23% from its highs, investors will be paying close attention to CVS Health's (CVS) fourth-quarter earnings on February 8.
2023-01-27 08:17:09 - MarketBeat
Mergers and Acquisitions in 2023 Off To A Strong Start
Mergers and acquisitions are a normal part of business, but 2023 has already presented many opportunities across the biotech industry. The M&A surge seems to be driven by two major transactions: the $6 billion sale of LHC Group Inc. (Nasdaq: LHCG) to UnitedHealth (NYSE: UNH) and the $8 billion sale of Signify Health Inc. (NYSE: SGFY) to CVS Health Co. (NYSE: CVS).
2023-01-13 21:04:05 - Zacks Investment Research
Time to Buy CVS or Oak Street Health Stock on Potential Acquisition?
News of CVS Health (CVS) potentially acquiring Oak Street Health (OHS) for $10 billion broke this week and highlighted what could be another lucrative acquisition in 2023.
2023-01-06 09:30:57 - MarketBeat
How 2022's Biggest Healthcare Gainers Could Fare In 2023
Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023